Patents by Inventor Dieter Oesterhelt

Dieter Oesterhelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230226056
    Abstract: The present invention relates to the use of organic and highly water-soluble compatible solutes or a solute mixture, preferably in the form of an inhalable, oropharyngeally, nasally and intravenously administrable composition, in the prevention or treatment of diseases caused by ss(+)RNA viruses of the Coronavriridae family, preferably of those diseases caused by SARS-CoV-1, SARS-CoV-2, MERS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63 and/or HCoV-229E. Particularly suitable solutes in the meaning of the invention are ectoine and its derivatives, Glycoin, mannosylglycerate (Firoin) and mannosylglyceramide (Firoin-A), which, due to their strong water-binding capacity, reduce the binding of the viruses to the receptors of the host cell in the transitional epithelium, e.g. eye, in the internal epithelium, e.g. lung, and in the endothelium and thus reduce or prevent the multiplication of the viruses.
    Type: Application
    Filed: May 10, 2021
    Publication date: July 20, 2023
    Applicant: bitop AG
    Inventors: Thomas SCHWARZ, Eva GALIK, Dieter OESTERHELT
  • Patent number: 7939220
    Abstract: The invention relates to proton-translocating retinal proteins which exhibit a photocycle which is retarded as compared with the wild type and whose all-trans retinal contents in the light-adapted and dark-adapted states do not differ from each other by more than 10%. The invention furthermore relates to a photochromic composition and to the use of the proton-translocating retinal proteins and the photochromic composition.
    Type: Grant
    Filed: July 27, 2001
    Date of Patent: May 10, 2011
    Assignee: Mib Munich Innovative Biomaterials GmbH
    Inventors: Dieter Oesterhelt, Norbert Hampp, Matthias Pfeiffer
  • Publication number: 20040054141
    Abstract: The invention relates to proton-translocating retinal proteins which exhibit a photocycle which is retarded as compared with the wild type and whose all-trans retinal contents in the light-adapted and dark-adapted states do not differ from each other by more than 10%. The invention furthermore relates to a photochromic composition and to the use of the proton-translocating retinal proteins and the photochromic composition.
    Type: Application
    Filed: September 8, 2003
    Publication date: March 18, 2004
    Inventors: Dieter Oesterhelt, Norbert Hampp, Matthias Pfeiffer
  • Patent number: 6274279
    Abstract: Compositions of bacteriorhodopsin variants with increased memory time and their use for reversible optical information recording are disclosed. The compositions are characterized in that the configuration of the retinal of the photoproduct is different from the configuration of the retinal of the initial state and other than 13-cis; the pH value of the composition lies between 3 and 11; the water content of the composition lies between 1 and 30% by weight with respect to the total weight of the composition; and additives for modulating the proton mobility are present in a concentration between 1 and 80% by weight of the mass of purple membrane composition used, and if required matrix materials in a concentration of up to 10% by weight with respect to the total weight of the composition are present. These compositions may be used in reversible information recording systems.
    Type: Grant
    Filed: February 3, 1995
    Date of Patent: August 14, 2001
    Assignee: MIB Munich Innovative Biomaterials GmbH
    Inventors: Norbert Hampp, Andreas Popp, Dieter Oesterhelt, Christoph Bräuchle
  • Patent number: 6197387
    Abstract: The invention relates to the production of thin metal layers and structures thereof on substrates of various structures. The lateral extent of a metal layer on the respective substrate can be prescribed with a precision in the micron and submicron range. The method described makes it possible to manufacture flat and three-dimensional metal structures on smooth planar or curved surfaces, as are required, for example, for depicting writing or drawings. The method uses no printing techniques.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: March 6, 2001
    Assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E. V., Atotech Deutschland GmbH
    Inventors: Stefan Fiedler, Dieter Oesterhelt, Heinrich Meyer, Wolfgang Scheel, Herbert Reichl
  • Patent number: 5374492
    Abstract: Purple membrane preparations having an increased holographic diffraction efficiency. The purple membrane preparations have a diffraction efficiency of less than 5 seconds and a resolution of greater than 1,500 lines/mm. The purple membrane preparations are obtainable by adjusting a purple membrane suspension having a photocycle time of at least 10 ms to a pH of between 6 and 11 by means of a buffer, adding from 1% to 10% by weight of a proton donor to this purple membrane suspension, and drying the resultant suspension down to a water content of from 1% to 30% by weight.
    Type: Grant
    Filed: September 11, 1992
    Date of Patent: December 20, 1994
    Assignee: Consortium fur elektrochemische Industrie GmbH
    Inventors: Norbert Hampp, Andreas Popp, Alfred Miller, Christoph Brauchle, Dieter Oesterhelt
  • Patent number: 5290699
    Abstract: Double mutants of bacteriorhodopsin are mutated in the amino acid positions 85 and 96 and are expressed in Halobacteria. The mutants have an altered absorption maximum of their ground state and of their intermediate with the longest life. These mutants pump anions in place of protons.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: March 1, 1994
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Dieter Oesterhelt, Susanne Meessen, Jorg Tittor, Anja Matuszak, Klaus May
  • Patent number: 5223355
    Abstract: In processes of holography using bacteriorhodopsin-based recording media, it is essential to design the signal-to-noise ratio to be as favorable as possible. This is achieved by recording the hologram using circularly polarized light and reconstructing the hologram by using linearly polarized light, specific beam components being selected as a function of polarization in the beam path of the reconstructed hologram. The process is suitable both for purely holographic applications and also for other processes which include one or more intermediate or partial steps involving holography.
    Type: Grant
    Filed: February 11, 1991
    Date of Patent: June 29, 1993
    Assignee: Consortium fur elektrochemische Industrie GmbH
    Inventors: Norbert Hampp, Ralph Thoma, Dieter Oesterhelt, Christoph Brauchle